069620•KO
Need professional-grade analysis? Visit stockanalysis.com
₩148,300.00
-2.69%
End of day
Market Cap
$1.70T
P/E Ratio
8.68
Employees
1,644
Dividend Yield
0.40%
Price Chart
Risk-Adjusted Performance
Daewoong Pharma (069620) Price Performance
Daewoong Pharma (069620) trades on KO in KRW. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at KRW148300.00, down 2.69% from the previous close.
Over the past year, 069620 has traded between a low of KRW129300.00 and a high of KRW194000.00. The stock has gained 3.8% over this period. It is currently 23.6% below its 52-week high.
Daewoong Pharma has a market capitalization of $1.70T, with a price-to-earnings ratio of 8.68 and a dividend yield of 0.40%.
About Daewoong Pharma
Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.
Company Info
- Sector
- Healthcare
- Exchange
- KO
- Currency
- KRW
- Country
- South Korea
Financial Metrics
- Revenue (TTM)
- $1.57T
- EBITDA
- $246.58B
- Profit Margin
- 12.47%
- EPS (TTM)
- N/A
- Book Value
- 1006093.32
Technical Indicators
- 52 Week High
- ₩199,400.00
- 52 Week Low
- ₩128,900.00
- 50 Day MA
- ₩161,434.00
- 200 Day MA
- ₩156,890.50
- Beta
- 0.16
Valuation
- Trailing P/E
- 8.68
- Forward P/E
- N/A
- Price/Sales
- 1.08
- Price/Book
- 1.74
- Enterprise Value
- $2.40T